Provided by Tiger Trade Technology Pte. Ltd.

Silence Therapeutics Plc

10.64
-0.0700-0.65%
Post-market: 10.660.0150+0.14%19:30 EDT
Volume:973.33K
Turnover:10.31M
Market Cap:661.32M
PE:-8.38
High:10.78
Open:10.77
Low:10.38
Close:10.71
52wk High:17.58
52wk Low:4.19
Shares:62.15M
Float Shares:50.17M
Volume Ratio:0.89
T/O Rate:1.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2693
EPS(LYR):-1.8761
ROE:-90.41%
ROA:-29.65%
PB:17.19
PE(LYR):-5.67

Loading ...

European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading

MT Newswires Live
·
Oct 02

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading

MT Newswires Live
·
Sep 23

Silence Therapeutics (SLN) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Sep 22

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading

MT Newswires Live
·
Sep 17

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Sep 15

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Sep 09

European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

MT Newswires Live
·
Sep 08

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Reuters
·
Sep 07

Silence Therapeutics to Join Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02

European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading

MT Newswires Live
·
Aug 31

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Cardinal Health (CAH) and Allogene Therapeutics (ALLO)

TIPRANKS
·
Aug 17

Silence Therapeutics Closes Upsized $201.3 Million ADS Follow-on Offering at $13.5 Each

Reuters
·
Aug 15

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Silence Therapeutics 10% Owner Richard Ian Griffiths Disposes of ADS Worth $87.88 Million

Reuters
·
Aug 13

U.S. Stocks on the MOVE-Sutro Biopharma, Humacyte

Reuters
·
Aug 13

Silence Therapeutics Prices Upsized $175 Million ADS Offering at $13.5 Each

Reuters
·
Aug 12

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Aug 11

Silence Therapeutics' Divesiran Data Support Best-in-Class Potential, Morgan Stanley Says

MT Newswires Live
·
Aug 11

Silence Therapeutics (SLN) Receives a Buy from Morgan Stanley

TIPRANKS
·
Aug 11